- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06687226
Food DNA Digestion
Digestion and Transit of Food DNA Through the Human Gut
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Transit time, the duration for ingested food to travel from ingestion to excretion, is crucial because it influences nutrient absorption, digestion efficiency, gut microbiome composition and the overall health of the gastrointestinal system. While numerous studies have focused on the breakdown of food components such as protein, fat and carbohydrates, the fate of food DNA, an integral part of the cells constituting these foods, remains less explored. Mouse studies indicate that food DNA can be traced in various sections of the digestive tract, with the greatest amount of degradation seen in the stomach. Human studies have supported these reports through showing significant dietary DNA degradation in the stomach and other food components in the stomach not significantly impact the efficiency of this degradation. However, this process is not 100% efficient as residual DNA has been shown to be detectable in stool in levels that are informative for health and epidemiological purposes. How long this residual DNA remains in the digestive tract and as such, the overall transit time and digestion rate for food DNA to be completely depleted from the digestive tract remain an open question.
In this study, the investigators will carry out a behavioral intervention in healthy human participants designed to investigate the transit time of dietary DNA. The design of this study is informed by the PI's previous experience with dietary interventions in human cohorts to better understand the human gut microbiome. This prior experience includes conducting a longitudinal study where samples as well as behavioral and dietary metadata were collected from human volunteers in addition to interventional studies of dietary supplements or fully controlled diets.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Veronica M Carrion
- Phone Number: 919-660-7341
- Email: vmp19@duke.edu
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Medical Sciences Research Building III (MSRB III)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Above age 18?
- Able to provide stool samples at no risk to the participant?
- Does the participant have card access to the MSRBIII building, and is the participant able to visit this building (at times of the participant's convenience) for the purposes of this study?
Exclusion Criteria:
- Already consume camu camu, maqui or kelp in typical diet?
- Have a history or current diagnosis of irritable bowel syndrome?
- Have a history or current diagnosis of inflammatory bowel disease?
- Have a history or current diagnosis of type 2 diabetes?
- Have a history or current diagnosis of chronic kidney disease with decreased kidney function?
- Have a history or current diagnosis of intestinal obstruction?
- Have a history or current diagnosis of untreated colorectal cancer?
- Has the participant had a colonoscopy within the past month?
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Stool samples + consumption of powdered food
Each participant will submit a baseline stool sample, consume a single dose of a study-specific powdered food (reconstituted in water) differing from their usual diet, and provide the subsequent five stool samples.
If five samples are collected in fewer than five days, an additional sample will be obtained on the fifth day post-consumption
|
During the intervention week, participants will be asked take one dose of a reconstitutable food powder provided in a ziplock bag.
This powder will be a mix of Gatorade Zero Powder (1 serving) and 1 serving of commercially available powders of either one or all of the following: camu camu, kelp or maqui.
The powder mix in the bag will be added to water and drunk by the participant as soon as possible after having a bowel movement (baseline stool sample).
Food powders are sourced from reputable companies and are safe for consumption (Gatorade is a wellrecognized brand and available in grocery stores nationally, Navitas Organics provides certified organic, third-party tested plant food powders with fairtrade certification).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transit time of naturally occurring food DNA through the human digestive tract
Time Frame: Approximately 5-8 days
|
Determined by quantifying the presence of food DNA in stool samples over a specified period post-consumption.
|
Approximately 5-8 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of food DNA depletion
Time Frame: Approximately 5-8 days
|
Evaluating the potential implications of the rate of food DNA depletion for nutrient absorption and gut microbiome interactions.
|
Approximately 5-8 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lawrence David, Duke University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00115407
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Digestion Rate
-
Deerland EnzymesKennesaw State UniversityRecruitingSatiety | Indigestion | Digestive Health | Protein Digestion | Carbohydrate Digestion | Fat DigestionUnited States
-
Efforia, IncActive, not recruiting
-
Wageningen UniversityCompleted
-
Newcastle UniversityCompletedTriacylglycerol DigestionUnited Kingdom
-
DSM Food SpecialtiesCompleted
-
Wageningen UniversityFrieslandCampinaCompleted
-
NIZO Food ResearchFrieslandCampinaCompleted
-
Maastricht University Medical CenterFrieslandCampinaCompletedProtein Digestion & AbsorptionNetherlands
-
NestléCompletedHappiness | Digestion | TemperamentChina
Clinical Trials on Reconstitutable food powder
-
University of GeorgiaEgg Nutrition CenterCompletedBone Health | Cognitive HealthUnited States
-
Dr. Schär AG / SPAASST Gaetano Pini-CTOCompleted
-
Children's Hospital of Fudan UniversityTerminated
-
Tata Memorial CentreRecruitingHepatocellular Carcinoma | ASA I-III PatientsIndia
-
Huilian ZhuNot yet recruiting
-
University of South CarolinaSusan G. Komen Breast Cancer FoundationCompleted
-
University of UtahCompletedSleep | Body Weight Changes | Recovery | Athletic PerformanceUnited States
-
International Centre for Diarrhoeal Disease Research...BracRecruitingFeeding Behavior | Child Malnutrition | Growth; Stunting, NutritionalBangladesh
-
University of California, DavisCompletedEffect of Food SupplementUnited States